Elevated serotonin 1A binding in remitted major depressive disorder: evidence for a trait biological abnormality.
about
Transcriptional regulation of the 5-HT1A receptor: implications for mental illnessHigher in vivo serotonin-1a binding in posttraumatic stress disorder: a PET study with [11C]WAY-100635Serotonin-1A receptor alterations in depression: a meta-analysis of molecular imaging studies.Molecular imaging for depressive disorders.Molecular, Functional, and Structural Imaging of Major Depressive Disorder.Brain serotonin 1A receptor binding as a predictor of treatment outcome in major depressive disorder.Effects of early-life stress on serotonin(1A) receptors in juvenile Rhesus monkeys measured by positron emission tomographySexually dimorphic serotonergic dysfunction in a mouse model of Huntington's disease and depression.Higher serotonin 1A binding in a second major depression cohort: modeling and reference region considerationsF15599, a highly selective post-synaptic 5-HT(1A) receptor agonist: in-vivo profile in behavioural models of antidepressant and serotonergic activity.The serotonergic system in the neurobiology of depression: Relevance for novel antidepressants.Enhanced 5-HT1A receptor-dependent feedback control over dorsal raphe serotonin neurons in the SERT knockout mouseFamilial risk for major depression is associated with lower striatal 5-HT₄ receptor bindingCortical shape and curvedness analysis of structural deficits in remitting and non-remitting depression.5-HT₁A receptor binding is increased after recovery from bulimia nervosa compared to control women and is associated with behavioral inhibition in both groupsPositron emission tomography quantification of serotonin(1A) receptor binding in suicide attempters with major depressive disorder.Transcriptional dys-regulation in anxiety and major depression: 5-HT1A gene promoter architecture as a therapeutic opportunity.Treatment of depressive-like behaviour in Huntington's disease mice by chronic sertraline and exercise.Genetic Variations in the Serotonergic System Mediate a Combined, Weakened Response to SSRI Treatment: A Proposed Model(1,2)Positron emission tomography quantification of serotonin transporter binding in medication-free bipolar disorder.Imaging the serotonin 1A receptor using [11C]WAY100635 in healthy controls and major depressionAntidepressant treatment reduces serotonin-1A autoreceptor binding in major depressive disorderQuantification of the Serotonin 1A Receptor Using PET: Identification of a Potential Biomarker of Major Depression in MalesPositron emission tomography quantification of serotonin transporter in suicide attempters with major depressive disorderImpact of Depression and Inflammation on the Progression of HIV Disease.The 5-HT1A receptor in Major Depressive DisorderOestrogen: an overlooked mediator in the neuropsychopharmacology of treatment response?Serotonin: imaging findings in eating disorders.Molecular imaging in patients with mood disorders: a review of PET findings.Serotonin and molecular neuroimaging in humans using PET.Molecular Neurobiology of Depression: PET Findings on the Elusive Correlation with Symptom Severity.The influence of the rs6295 gene polymorphism on serotonin-1A receptor distribution investigated with PET in patients with major depression applying machine learning.Prediction of selective serotonin reuptake inhibitor response using diffusion-weighted MRI.Regulatory Pathways of Monoamine Oxidase A during Social Stress.Will imaging individual raphe nuclei in males with major depressive disorder enhance diagnostic sensitivity and specificity?Evaluation of peripheral serotonin content and α2-adrenergic receptor function as potential markers for life-long recurrent depressive disorder by using methodological improvements.Quantification of 5-HT1A and 5-HT2A Receptor Binding in Depressed Suicide Attempters and Non-Attempters.A positron emission tomography study of the serotonergic system in relation to anxiety in depression.Different patterns of 5-HT receptor and transporter dysfunction in neuropsychiatric disorders--a comparative analysis of in vivo imaging findings.Measuring endogenous changes in serotonergic neurotransmission in humans: a [11C]CUMI-101 PET challenge study.
P2860
Q26999691-CFD7E93E-3C4C-4B1B-8255-DB6B5FCC2B45Q28389170-A001B888-0525-478F-9E7A-A85707B67ED1Q30245389-5B73EAC1-B94F-4876-92AC-EBE547C0AF43Q30821361-51F59058-E77C-42AB-A5EC-AEC0A460CC05Q31090058-B75E4C9E-A8B3-47C7-B9C4-0F5B797ACA7FQ33792011-DCC1BDFC-1521-4B63-8D38-8CE615187C98Q33900907-25B25CF9-A6FA-4B8C-B7CD-B7FE44D505F7Q33961770-2044135A-9852-410C-BFFA-C65C475DFA80Q33976272-DD336530-436C-49A7-AF09-4FE1FC66FC3BQ34091711-E7B1B020-DCC4-4726-83A3-8EA9EA81BBF2Q34497909-A5DFA8FF-8640-4A85-A8A5-741A066B7FD3Q34603228-E5F0385E-DBE3-46E1-AFDA-3616E96FAEE3Q34667157-4B164685-F9FA-4A9D-A9E6-77E5030506D7Q34849885-DAE67B05-FF29-4625-A490-48851E1E6411Q34856647-EC1BBD7B-C3BB-47AA-97D9-A877449D093DQ35087781-8D9C836B-8FCC-404C-AE84-7EAFA4F12C16Q35887986-31BF1BE0-590C-4213-8100-5AAEC84C1626Q36024880-0066550B-5CB2-493C-8DFC-51E2F2FC1C38Q36103263-CB30B8A5-4A52-465C-A62C-154E59AD802BQ36303529-EF08D27A-63ED-47D8-B14B-38E1DD3D73ABQ36801178-5E3E13F6-11D2-4D02-A4CB-D3E7D1F4799DQ36948231-D20CAEF9-5281-441B-BD55-73E2A274AA2AQ37024830-092DE394-CC61-4FAB-89E9-683F8D9ECF9FQ37049887-A72EEF84-D3CF-472F-B7F7-7C5E373303C6Q37138606-FAE71D94-A628-40D5-A753-5FC69AA6305AQ37538381-14189379-0D27-47BF-8E2E-3E63FAF781D7Q37791238-B9FCB177-E7FB-41E7-8FCC-B944DDB1AADDQ37829680-1F6A906B-A622-415A-A30C-E8496C39C9F8Q37864156-42B6F2C0-28F3-4FE3-8B6D-70AE1EDC1E84Q37938794-74B467C0-6187-4B6B-BE1A-C1FFF864702EQ38086422-E156329A-0082-4BE5-A805-3E293EAB57DCQ38671559-BCF67D48-F85A-4421-993B-D70847A8F325Q41551746-FAEB59B6-A7B5-4E4D-B809-4360976DC22EQ47171927-FCCB95FC-A6BD-4ACB-BE1E-FAFE165E6488Q47557026-06790D3B-0202-4FD0-BBDB-DE7D51FEDBCFQ47584940-D20276B5-E643-4D6A-BE41-AB8589908C63Q47667959-DCA03318-169D-47FE-B9D1-07EFA9032032Q47724853-109F9A79-AEC5-44CA-A1CD-2550A95235A4Q48074706-4EF12290-B021-4C76-B0BE-286421B754EFQ48483797-3C3121B4-D997-4902-A241-B1BE5E9AC516
P2860
Elevated serotonin 1A binding in remitted major depressive disorder: evidence for a trait biological abnormality.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 May 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Elevated serotonin 1A binding ...... trait biological abnormality.
@en
Elevated serotonin 1A binding ...... trait biological abnormality.
@nl
type
label
Elevated serotonin 1A binding ...... trait biological abnormality.
@en
Elevated serotonin 1A binding ...... trait biological abnormality.
@nl
prefLabel
Elevated serotonin 1A binding ...... trait biological abnormality.
@en
Elevated serotonin 1A binding ...... trait biological abnormality.
@nl
P2093
P2860
P356
P1476
Elevated serotonin 1A binding ...... trait biological abnormality.
@en
P2093
Gregory M Sullivan
J John Mann
Jeffrey M Miller
Kathleen G Brennan
Ramin V Parsey
Todd R Ogden
P2860
P2888
P304
P356
10.1038/NPP.2009.54
P407
P577
2009-05-20T00:00:00Z
P5875
P6179
1041832790